Scientists generate 3D ultra-resolution maps of mitochondrial networks in lung tumors

Scientists have long known that mitochondria, the "powerhouses" of cells, play a crucial role in the metabolism and energy production of cancer cells. However, until now, little was known about the relationship between the structural organization of mitochondrial networks and their functional bioenergetic activity at the level of whole tumors.

In a new study, published in Nature, researchers from the UCLA Jonsson Comprehensive Cancer Center used positron emission tomography (PET) in combination with electron microscopy to generate 3-dimensional ultra-resolution maps of mitochondrial networks in lung tumors of genetically engineered mice. They categorized the tumors based on mitochondrial activity and other factors using an artificial intelligence technique called deep learning, quantifying the mitochondrial architecture across hundreds of cells and thousands of mitochondria throughout the tumor.

The authors examined two main subtypes of non-small cell lung cancer (NSCLC) -; adenocarcinomas and squamous-cell carcinomas and found distinct subpopulations of mitochondrial networks within these tumors. Importantly, they discovered that the mitochondria frequently organize themselves with organelles such as lipid droplets to create unique subcellular structures that support tumor cell metabolism and mitochondrial activity.

The study was led by Mingqi Han, Ph.D., a post-doctoral researcher in the lab of David Shackelford, Ph.D. Dr. Shackelford is a UCLA Jonsson Comprehensive Cancer Center member and Associate Professor of Pulmonary and Critical Care Medicine at the UCLA David Geffen School of Medicine.

The authors anticipate that mitochondrial populations in human cancer samples will not be mutually exclusive to their respective tumor subtype, but rather there will be a spectrum of activity.

The investigators say these findings provide key information about the function of mitochondria in cancer cells and could lead to new approaches to cancer treatment.

Our study represents a first step towards generating highly detailed 3-dimensional maps of lung tumors using genetically engineered mouse models. Using these maps, we have begun to create a structural and functional atlas of lung tumors, which has provided us valuable insight into how tumor cells structurally organize their cellular architecture in response to the high metabolic demands of tumor growth. Our findings hold promise to inform and improve current treatment strategies while illuminating new directions from which to target lung cancer."

Dr. David Shackelford, Ph.D., UCLA Jonsson Comprehensive Cancer Center Member and Associate Professor of Pulmonary and Critical Care Medicine at the UCLA David Geffen School of Medicine

"Our study has uncovered a novel finding in the metabolic flux of lung tumors, revealing that their nutrient preference may be determined by the compartmentalization of their mitochondria with other organelles, either relying on glucose ("sugar") or free fatty acids ("fat")," said Dr. Han. "This discovery has important implications for developing effective anti-cancer therapies that target tumor-specific nutrient preferences. Our multi-modality imaging approach has enabled us to uncover this previously unknown aspect of cancer metabolism, and we believe that it can be applied to other types of cancer, paving the way for further research in this area."

Source:
Journal reference:

Han, M., et al. (2023). Spatial mapping of mitochondrial networks and bioenergetics in lung cancer. Nature doi.org/10.1038/s41586-023-05793-3.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Targeted gene therapy shuts down cancer cells' energy centers